Model
Edge
Alnylam Pharmaceuticals, Inc.
0001886431
Filing Type
144
Filing Date
2/16/2026
Updated
2/17/26, 2:10 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities